Coverage and side effects of influenza A(H1N1) 2009 monovalent vaccine among primary health care workers.
Identifieur interne : 000412 ( Main/Exploration ); précédent : 000411; suivant : 000413Coverage and side effects of influenza A(H1N1) 2009 monovalent vaccine among primary health care workers.
Auteurs : Miguel Angel Ortiz Arjona [Espagne] ; Khaled Mahmoud Abd Elaziz ; Jose Maria Caballero Lanzas ; Mohamed Farouk AllamSource :
- Vaccine [ 1873-2518 ] ; 2011.
Descripteurs français
- KwdFr :
- Attitude du personnel soignant (MeSH), Enquêtes et questionnaires (MeSH), Espagne (MeSH), Femelle (MeSH), Humains (MeSH), Mâle (MeSH), Observance par le patient (MeSH), Personnel de santé (MeSH), Soins de santé primaires (MeSH), Sous-type H1N1 du virus de la grippe A (immunologie), Vaccination (MeSH), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (effets indésirables), Vaccins antigrippaux (immunologie), Épidémies de maladies (prévention et contrôle).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- effets indésirables : Vaccins antigrippaux.
- immunologie : Sous-type H1N1 du virus de la grippe A, Vaccins antigrippaux.
- prévention et contrôle : Épidémies de maladies.
- Attitude du personnel soignant, Enquêtes et questionnaires, Espagne, Femelle, Humains, Mâle, Observance par le patient, Personnel de santé, Soins de santé primaires, Vaccination.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Attitude of Health Personnel (MeSH), Disease Outbreaks (prevention & control), Female (MeSH), Health Personnel (MeSH), Humans (MeSH), Influenza A Virus, H1N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza Vaccines (adverse effects), Influenza Vaccines (immunology), Male (MeSH), Patient Compliance (MeSH), Primary Health Care (MeSH), Spain (MeSH), Surveys and Questionnaires (MeSH), Vaccination (MeSH).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , adverse effects : Influenza Vaccines.
- geographic : Spain.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza Vaccines.
- prevention & control : Disease Outbreaks.
- Attitude of Health Personnel, Female, Health Personnel, Humans, Male, Patient Compliance, Primary Health Care, Surveys and Questionnaires, Vaccination.
Abstract
In June 2009, WHO declared the maximum phase alert against H1N1 pandemic flu. Health care workers (HCWs) are considered a strategic target for prevention of the occurrence of H1N1 influenza since they had the greatest risk of acquiring infection. The objectives of our study were (1) identifying the uptake of influenza A(H1N1) 2009 monovalent vaccine by primary health care workers in the southern part of Cordoba, and (2) reporting of the adverse events occurred after vaccination. We followed 240 HCWs in 12 primary health care centres at southern part of Cordoba for vaccine uptake and the occurrence of adverse events. The coverage rate with H1N1 vaccine was 20.5% which was lower compared to seasonal influenza vaccination rate 44.2% in 2009. Males had higher H1N1 vaccination rate compared to females with no significant difference. Senior HCWs complied more with seasonal influenza vaccine while this finding was not consistent with H1N1 vaccination. Multivariate analysis showed that the only independent variable that affected H1N1 vaccine was the compliance to the seasonal flu vaccine in the past three years with OR 5.1 and 95% CI (2.4-10.8). Adverse events occurred among 26.5% of those who complied with H1N1 vaccination. Those were local pain, irritation and induration at site of injection (38.5%), fever (15.4%), fever cough and rhinorrhea (15.4%) generalized pain and lumber pains (23.1%). The low vaccination rate in this study is consistent with previous studies done in many parts of the world and in Spain. Further studies should be done to explore the factors that hindered the uptake and resistance of HCWs to vaccination to H1N1 vaccine.
DOI: 10.1016/j.vaccine.2011.04.117
PubMed: 21840463
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Coverage and side effects of influenza A(H1N1) 2009 monovalent vaccine among primary health care workers.</title><author><name sortKey="Ortiz Arjona, Miguel Angel" sort="Ortiz Arjona, Miguel Angel" uniqKey="Ortiz Arjona M" first="Miguel Angel" last="Ortiz Arjona">Miguel Angel Ortiz Arjona</name><affiliation wicri:level="1"><nlm:affiliation>Aguilar Health Care Centre, South Cordoba Health District, Aguilar, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Aguilar Health Care Centre, South Cordoba Health District, Aguilar</wicri:regionArea><wicri:noRegion>Aguilar</wicri:noRegion></affiliation></author><author><name sortKey="Abd Elaziz, Khaled Mahmoud" sort="Abd Elaziz, Khaled Mahmoud" uniqKey="Abd Elaziz K" first="Khaled Mahmoud" last="Abd Elaziz">Khaled Mahmoud Abd Elaziz</name></author><author><name sortKey="Caballero Lanzas, Jose Maria" sort="Caballero Lanzas, Jose Maria" uniqKey="Caballero Lanzas J" first="Jose Maria" last="Caballero Lanzas">Jose Maria Caballero Lanzas</name></author><author><name sortKey="Allam, Mohamed Farouk" sort="Allam, Mohamed Farouk" uniqKey="Allam M" first="Mohamed Farouk" last="Allam">Mohamed Farouk Allam</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21840463</idno><idno type="pmid">21840463</idno><idno type="doi">10.1016/j.vaccine.2011.04.117</idno><idno type="wicri:Area/Main/Corpus">00348</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00348</idno><idno type="wicri:Area/Main/Curation">000348</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000348</idno><idno type="wicri:Area/Main/Exploration">000348</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Coverage and side effects of influenza A(H1N1) 2009 monovalent vaccine among primary health care workers.</title><author><name sortKey="Ortiz Arjona, Miguel Angel" sort="Ortiz Arjona, Miguel Angel" uniqKey="Ortiz Arjona M" first="Miguel Angel" last="Ortiz Arjona">Miguel Angel Ortiz Arjona</name><affiliation wicri:level="1"><nlm:affiliation>Aguilar Health Care Centre, South Cordoba Health District, Aguilar, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Aguilar Health Care Centre, South Cordoba Health District, Aguilar</wicri:regionArea><wicri:noRegion>Aguilar</wicri:noRegion></affiliation></author><author><name sortKey="Abd Elaziz, Khaled Mahmoud" sort="Abd Elaziz, Khaled Mahmoud" uniqKey="Abd Elaziz K" first="Khaled Mahmoud" last="Abd Elaziz">Khaled Mahmoud Abd Elaziz</name></author><author><name sortKey="Caballero Lanzas, Jose Maria" sort="Caballero Lanzas, Jose Maria" uniqKey="Caballero Lanzas J" first="Jose Maria" last="Caballero Lanzas">Jose Maria Caballero Lanzas</name></author><author><name sortKey="Allam, Mohamed Farouk" sort="Allam, Mohamed Farouk" uniqKey="Allam M" first="Mohamed Farouk" last="Allam">Mohamed Farouk Allam</name></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Attitude of Health Personnel (MeSH)</term><term>Disease Outbreaks (prevention & control)</term><term>Female (MeSH)</term><term>Health Personnel (MeSH)</term><term>Humans (MeSH)</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (adverse effects)</term><term>Influenza Vaccines (immunology)</term><term>Male (MeSH)</term><term>Patient Compliance (MeSH)</term><term>Primary Health Care (MeSH)</term><term>Spain (MeSH)</term><term>Surveys and Questionnaires (MeSH)</term><term>Vaccination (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Attitude du personnel soignant (MeSH)</term><term>Enquêtes et questionnaires (MeSH)</term><term>Espagne (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Mâle (MeSH)</term><term>Observance par le patient (MeSH)</term><term>Personnel de santé (MeSH)</term><term>Soins de santé primaires (MeSH)</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Vaccination (MeSH)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (effets indésirables)</term><term>Vaccins antigrippaux (immunologie)</term><term>Épidémies de maladies (prévention et contrôle)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Épidémies de maladies</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Attitude of Health Personnel</term><term>Female</term><term>Health Personnel</term><term>Humans</term><term>Male</term><term>Patient Compliance</term><term>Primary Health Care</term><term>Surveys and Questionnaires</term><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Attitude du personnel soignant</term><term>Enquêtes et questionnaires</term><term>Espagne</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Observance par le patient</term><term>Personnel de santé</term><term>Soins de santé primaires</term><term>Vaccination</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In June 2009, WHO declared the maximum phase alert against H1N1 pandemic flu. Health care workers (HCWs) are considered a strategic target for prevention of the occurrence of H1N1 influenza since they had the greatest risk of acquiring infection. The objectives of our study were (1) identifying the uptake of influenza A(H1N1) 2009 monovalent vaccine by primary health care workers in the southern part of Cordoba, and (2) reporting of the adverse events occurred after vaccination. We followed 240 HCWs in 12 primary health care centres at southern part of Cordoba for vaccine uptake and the occurrence of adverse events. The coverage rate with H1N1 vaccine was 20.5% which was lower compared to seasonal influenza vaccination rate 44.2% in 2009. Males had higher H1N1 vaccination rate compared to females with no significant difference. Senior HCWs complied more with seasonal influenza vaccine while this finding was not consistent with H1N1 vaccination. Multivariate analysis showed that the only independent variable that affected H1N1 vaccine was the compliance to the seasonal flu vaccine in the past three years with OR 5.1 and 95% CI (2.4-10.8). Adverse events occurred among 26.5% of those who complied with H1N1 vaccination. Those were local pain, irritation and induration at site of injection (38.5%), fever (15.4%), fever cough and rhinorrhea (15.4%) generalized pain and lumber pains (23.1%). The low vaccination rate in this study is consistent with previous studies done in many parts of the world and in Spain. Further studies should be done to explore the factors that hindered the uptake and resistance of HCWs to vaccination to H1N1 vaccine.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21840463</PMID><DateCompleted><Year>2012</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>37</Issue><PubDate><Year>2011</Year><Month>Aug</Month><Day>26</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Coverage and side effects of influenza A(H1N1) 2009 monovalent vaccine among primary health care workers.</ArticleTitle><Pagination><MedlinePgn>6366-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2011.04.117</ELocationID><Abstract><AbstractText>In June 2009, WHO declared the maximum phase alert against H1N1 pandemic flu. Health care workers (HCWs) are considered a strategic target for prevention of the occurrence of H1N1 influenza since they had the greatest risk of acquiring infection. The objectives of our study were (1) identifying the uptake of influenza A(H1N1) 2009 monovalent vaccine by primary health care workers in the southern part of Cordoba, and (2) reporting of the adverse events occurred after vaccination. We followed 240 HCWs in 12 primary health care centres at southern part of Cordoba for vaccine uptake and the occurrence of adverse events. The coverage rate with H1N1 vaccine was 20.5% which was lower compared to seasonal influenza vaccination rate 44.2% in 2009. Males had higher H1N1 vaccination rate compared to females with no significant difference. Senior HCWs complied more with seasonal influenza vaccine while this finding was not consistent with H1N1 vaccination. Multivariate analysis showed that the only independent variable that affected H1N1 vaccine was the compliance to the seasonal flu vaccine in the past three years with OR 5.1 and 95% CI (2.4-10.8). Adverse events occurred among 26.5% of those who complied with H1N1 vaccination. Those were local pain, irritation and induration at site of injection (38.5%), fever (15.4%), fever cough and rhinorrhea (15.4%) generalized pain and lumber pains (23.1%). The low vaccination rate in this study is consistent with previous studies done in many parts of the world and in Spain. Further studies should be done to explore the factors that hindered the uptake and resistance of HCWs to vaccination to H1N1 vaccine.</AbstractText><CopyrightInformation>Copyright © 2011 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ortiz Arjona</LastName><ForeName>Miguel Angel</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Aguilar Health Care Centre, South Cordoba Health District, Aguilar, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abd Elaziz</LastName><ForeName>Khaled Mahmoud</ForeName><Initials>KM</Initials></Author><Author ValidYN="Y"><LastName>Caballero Lanzas</LastName><ForeName>Jose Maria</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Allam</LastName><ForeName>Mohamed Farouk</ForeName><Initials>MF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001291" MajorTopicYN="Y">Attitude of Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>04</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21840463</ArticleId><ArticleId IdType="pii">S0264-410X(11)00683-9</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2011.04.117</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country></list><tree><noCountry><name sortKey="Abd Elaziz, Khaled Mahmoud" sort="Abd Elaziz, Khaled Mahmoud" uniqKey="Abd Elaziz K" first="Khaled Mahmoud" last="Abd Elaziz">Khaled Mahmoud Abd Elaziz</name><name sortKey="Allam, Mohamed Farouk" sort="Allam, Mohamed Farouk" uniqKey="Allam M" first="Mohamed Farouk" last="Allam">Mohamed Farouk Allam</name><name sortKey="Caballero Lanzas, Jose Maria" sort="Caballero Lanzas, Jose Maria" uniqKey="Caballero Lanzas J" first="Jose Maria" last="Caballero Lanzas">Jose Maria Caballero Lanzas</name></noCountry><country name="Espagne"><noRegion><name sortKey="Ortiz Arjona, Miguel Angel" sort="Ortiz Arjona, Miguel Angel" uniqKey="Ortiz Arjona M" first="Miguel Angel" last="Ortiz Arjona">Miguel Angel Ortiz Arjona</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000412 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000412 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21840463
|texte= Coverage and side effects of influenza A(H1N1) 2009 monovalent vaccine among primary health care workers.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21840463" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |